A detailed history of Logos Global Management LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 1,100,000 shares of TVTX stock, worth $20.1 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares
1,100,000
Holding current value
$20.1 Million
% of portfolio
2.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.89 - $15.21 $8.68 Million - $16.7 Million
1,100,000 New
1,100,000 $15.4 Million
Q1 2022

May 16, 2022

SELL
$23.61 - $30.6 $2.36 Million - $3.06 Million
-100,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$24.34 - $31.17 $2.43 Million - $3.12 Million
100,000 New
100,000 $3.1 Million
Q1 2021

May 17, 2021

SELL
$23.37 - $31.77 $1.43 Million - $1.94 Million
-61,152 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$19.17 - $27.87 $1.17 Million - $1.7 Million
61,152 New
61,152 $1.67 Million

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.17B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.